1. Home
  2. APT vs DBVT Comparison

APT vs DBVT Comparison

Compare APT & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APT
  • DBVT
  • Stock Information
  • Founded
  • APT 1983
  • DBVT 2002
  • Country
  • APT Canada
  • DBVT France
  • Employees
  • APT N/A
  • DBVT N/A
  • Industry
  • APT
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • APT
  • DBVT Health Care
  • Exchange
  • APT Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • APT 62.3M
  • DBVT 67.8M
  • IPO Year
  • APT 1995
  • DBVT N/A
  • Fundamental
  • Price
  • APT $5.90
  • DBVT $0.72
  • Analyst Decision
  • APT
  • DBVT Strong Buy
  • Analyst Count
  • APT 0
  • DBVT 2
  • Target Price
  • APT N/A
  • DBVT $5.00
  • AVG Volume (30 Days)
  • APT 20.1K
  • DBVT 52.4K
  • Earning Date
  • APT 11-05-2024
  • DBVT 10-29-2024
  • Dividend Yield
  • APT N/A
  • DBVT N/A
  • EPS Growth
  • APT 82.51
  • DBVT N/A
  • EPS
  • APT 0.41
  • DBVT N/A
  • Revenue
  • APT $61,090,000.00
  • DBVT $13,814,000.00
  • Revenue This Year
  • APT N/A
  • DBVT N/A
  • Revenue Next Year
  • APT N/A
  • DBVT $1,258.14
  • P/E Ratio
  • APT $14.50
  • DBVT N/A
  • Revenue Growth
  • APT 7.44
  • DBVT 163.02
  • 52 Week Low
  • APT $3.98
  • DBVT $0.50
  • 52 Week High
  • APT $6.92
  • DBVT $2.28
  • Technical
  • Relative Strength Index (RSI)
  • APT 55.54
  • DBVT 48.83
  • Support Level
  • APT $5.64
  • DBVT $0.68
  • Resistance Level
  • APT $6.00
  • DBVT $0.73
  • Average True Range (ATR)
  • APT 0.17
  • DBVT 0.04
  • MACD
  • APT 0.03
  • DBVT 0.01
  • Stochastic Oscillator
  • APT 59.71
  • DBVT 78.57

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: